Sutro Biopharma (STRO) Price to FCF (2018 - 2025)
Powered by 
Analysis
Sutro Biopharma (STRO) Price to FCF (2018 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn |
| 10 | Sutro Biopharma | 332.59 Mn | 168.25 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -3.73 |
| Sep 30, 2025 | -1.92 |
| Jun 30, 2025 | -1.35 |
| Mar 31, 2025 | -0.79 |
| Dec 31, 2024 | -2.09 |
| Sep 30, 2024 | -4.36 |
| Jun 30, 2024 | 27.57 |
| Mar 31, 2024 | -5.41 |
| Dec 31, 2023 | 20.72 |
| Sep 30, 2023 | -6.25 |
| Jun 30, 2023 | -8.57 |
| Mar 31, 2023 | -4.49 |
| Dec 31, 2022 | -17.06 |
| Sep 30, 2022 | 4.66 |
| Jun 30, 2022 | -47.08 |
| Mar 31, 2022 | -10.48 |
| Dec 31, 2021 | -28.58 |
| Sep 30, 2021 | -29.72 |
| Jun 30, 2021 | -80.35 |
| Mar 31, 2021 | -31.99 |